単位用量製造の世界市場レポート 2025年

単位用量製造市場規模は、今後数年で飛躍的な成長が見込まれます。2029年にはCAGR22.1％で881億1,000万米ドルに成長します。予測期間の成長は、医薬品製造におけるインダストリー4.0の採用、個別化医療と精密医療の重視、医薬品の安全性と有効性に対する規制の焦点、医薬品アウトソーシングの拡大、患者中心のドラッグデリバリーに対する需要の高まりに起因すると考えられます。予測期間における主な動向としては、単位用量製造における高度な自動化の導入、医薬品パッケージングにおけるIoTの統合、特定の医薬品に対する単位用量パッケージングのカスタマイズ、持続可能で環境に優しいパッケージング材料の採用、個別化された医薬品製造における3dプリンティングの成長などが挙げられます。

ヘルスケア支出の増加は、今後の単位用量製造市場の成長を促進すると予想されます。ヘルスケア支出には、医療サービス、家族計画活動、栄養プログラム、緊急健康支援などの提供に関連するすべての費用が含まれます。ヘルスケア支出の増加は、単位用量製造を含む様々な健康関連サービスの進歩・開拓を促進し、単位用量製造市場の成長を支えます。例えば、2024年9月、米国を拠点とするABAセラピーサービスのプロバイダーであるCross River Therapy社が発表した統計によると、米国の医薬品業界の売上高は5,500億米ドルでした。2021年、アメリカ人は医薬品に5,769億米ドルを費やしており、2025年には6,050億米ドルから6,350億米ドルに増加すると予測されています。したがって、ヘルスケア支出の増加が単位用量製造市場の成長を牽引しています。

個別化医療に対する需要が急増していることも、単位用量製造市場の成長を促す要因となっています。個別化医療とは、個人の遺伝子やタンパク質に関する知識を利用して、病気の予防、発見、治療を行うことです。単位用量製造は、患者の特定のニーズに合わせた個別用量を製造するためのプラットフォームを提供することで、個別化医療において極めて重要な役割を果たしています。個別化医療連合（Personalized Medicine Coalition）が強調しているように、2022年に新たに承認されたすべての治療用分子実体の約34％が個別化医療であり、そのような12の医薬品が米国食品医薬品局（FDA）から承認を受けた。このような個別化医療に対する需要の急増は、単位用量製造市場の拡大を推進する重要な要因となっています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界単位用量製造PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界の単位用量製造市場：成長率分析
• 世界の単位用量製造市場の実績：規模と成長, 2019-2024
• 世界の単位用量製造市場の予測：規模と成長, 2024-2029, 2034F
• 世界単位用量製造総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の単位用量製造市場：製品別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 液体単位用量
• 固形単位用量
• その他の製品
• 世界の単位用量製造市場調達先、実績と予測, 2019-2024, 2024-2029F, 2034F
• 社内
• アウトソーシング
• 世界の単位用量製造市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 独立薬局
• 長期ケア施設
• 病院
• その他のエンドユーザー
• 世界の単位用量製造市場、液体単位用量のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 液体バイアル
• アンプル
• プレフィルドシリンジ
• 世界の単位用量製造市場、固形単位用量のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• タブレット
• カプセル
• パウダーパック
• 世界の単位用量製造市場、その他の製品のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 経皮パッチ
• 吸入投与量
• 単位用量包装のクリームと軟膏

第7章 地域別・国別分析

• 世界の単位用量製造市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の単位用量製造市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 単位用量製造市場：競合情勢
• 単位用量製造市場：企業プロファイル
  • Nipro Corporation Overview, Products and Services, Strategy and Financial Analysis
  • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Amcor plc Overview, Products and Services, Strategy and Financial Analysis
  • Berry Global Overview, Products and Services, Strategy and Financial Analysis
  • CCL Industries Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Sealed Air Corporation
• Huhtamaki Oyj
• Catalent Inc.
• AptarGroup
• Schott AG
• West Pharmaceuticals Services Inc.
• Constantia Flexibles Group GmbH
• Gerresheimer AG
• RPC Group
• Klockner Pentaplast Group
• Stevanato Group
• Bemis Company
• Corden Pharma GmbH
• LTS Lohmann Therapie-Systeme AG
• PCI Pharma Services

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 単位用量製造市場2029：新たな機会を提供する国
• 単位用量製造市場2029：新たな機会を提供するセグメント
• 単位用量製造市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Unit dosage manufacturing involves the production of individual pre-packaged doses of drugs or other products containing a specific quantity of medication intended for single-dose administration. These doses are typically presented in easily administered forms such as tablets, capsules, or vials, facilitating patient dispensing.

The primary products of unit dose manufacturing include liquid unit dose, solid unit dose, and others. A liquid unit dose specifically denotes a predetermined and customized amount of liquid medication or chemical enclosed in a single packaging unit, typically designed for single-use delivery. The sourcing methods for unit dose manufacturing include both in-house production and outsourcing, with utilization by various entities such as independent pharmacies, long-term care facilities, hospitals, and others.

The unit dose manufacturing research report is one of a series of new reports from The Business Research Company that provides unit dose manufacturing market statistics, including the unit dose manufacturing industry's global market size, regional shares, competitors with unit dose manufacturing market share, detailed unit dose manufacturing market segments, market trends and opportunities, and any further data you may need to thrive in the unit dose manufacturing industry. This unit dose manufacturing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The unit dose manufacturing market size has grown exponentially in recent years. It will grow from $32.82 billion in 2024 to $39.7 billion in 2025 at a compound annual growth rate (CAGR) of 21.0%. The growth in the historic period can be attributed to traditional pharmaceutical manufacturing practices, regulatory developments in drug packaging, rise in demand for personalized medicine, growth of the aging population, and increased prevalence of chronic diseases

The unit dose manufacturing market size is expected to see exponential growth in the next few years. It will grow to $88.11 billion in 2029 at a compound annual growth rate (CAGR) of 22.1%. The growth in the forecast period can be attributed to the adoption of Industry 4.0 in pharmaceutical manufacturing, emphasis on personalized and precision medicine, regulatory focus on drug safety and efficacy, expansion of pharmaceutical outsourcing, and growing demand for patient-centric drug delivery. Major trends in the forecast period include the implementation of advanced automation in unit dose manufacturing, integration of IoT in pharmaceutical packaging, customization of unit dose packaging for specific drugs, adoption of sustainable and eco-friendly packaging materials, and growth of 3d printing in personalized drug manufacturing.

The increase in healthcare spending is expected to drive the growth of the unit dose manufacturing market in the future. Healthcare spending encompasses all costs related to providing health services, family planning activities, nutrition programs, and emergency health assistance. Rising healthcare expenditure will facilitate the advancement and development of various health-related services, including unit dose manufacturing, thereby supporting the growth of the unit dose manufacturing market. For instance, in September 2024, statistics published by Cross River Therapy, a US-based provider of ABA therapy services, indicated that the U.S. pharmaceutical industry generated $550 billion in revenue. In 2021, Americans spent $576.9 billion on medicine, with projected spending expected to rise to between $605 billion and $635 billion by 2025. Therefore, the increase in healthcare spending is driving the growth of the unit dose manufacturing market.

The burgeoning demand for personalized medicine is poised to be a key driver of growth in the unit dose manufacturing market. Personalized medicine involves the use of knowledge about an individual's genes or proteins to prevent, detect, or treat diseases. Unit dose manufacturing plays a pivotal role in personalized medicine by providing a platform for producing individualized doses tailored to the specific needs of patients. As highlighted by the Personalized Medicine Coalition, approximately 34% of all newly approved therapeutic molecular entities in 2022 were personalized medicines, with 12 such medicines receiving approval from the US Food and Drug Administration (FDA). This surge in demand for personalized medicine is a significant factor propelling the expansion of the unit dose manufacturing market.

Product innovations are a significant trend gaining traction in the unit-dose manufacturing market. Key companies in this sector are developing new products to maintain their competitive edge. For example, in August 2024, Eli Lilly and Company, a US-based pharmaceutical firm, announced the availability of Zepbound (tirzepatide) 2.5 mg and 5 mg single-dose vials for self-pay patients with an on-label prescription, thereby expanding access to meet growing demand. These vials are priced at a discount of 50% or more compared to the list prices of other incretin (GLP-1) obesity treatments. This new option provides affordable access to millions of adults with obesity, including those who are not eligible for the Zepbound savings card, those lacking employer-sponsored coverage, and those paying out-of-pocket without insurance.

Strategic partnerships are emerging as a prominent strategy adopted by major players to sustain and enhance their position in the unit dose manufacturing market. Strategic partnerships involve leveraging each other's strengths and resources to achieve mutual benefits and success. In November 2023, iA, a US-based provider of integrated pharmacy fulfillment platforms, announced a distributor agreement with Euclid Medical Products, a US-based specialist in multi-unit automated packaging and barcoding systems. This collaboration involves integrating Euclid's Axial Adherence Packaging Technology into iA's NEXiA Enterprise Software Suite, expanding the capabilities of centralized fulfillment solutions. This partnership offers multiple medication dispensing methods, including multi- and unit-dose automated packaging, providing comprehensive solutions to meet diverse healthcare needs.

In August 2022, LTS Lohmann Therapie-Systeme AG, a Germany-based pharmaceutical technology company specializing in drug delivery systems, acquired Tapemark Inc. for an undisclosed amount. This acquisition positions LTS Lohmann Therapie-Systeme AG as a leading contract development and manufacturing organization for transdermal patches and oral thin films while expanding its footprint in the US. Tapemark Inc., based in the US, is a full-service contract development and manufacturing organization specializing in transdermal, oral thin film, and unit-dose products. The acquisition reflects a commitment to growth and diversification within the unit dose manufacturing sector.

Major companies operating in the unit dose manufacturing market include Nipro Corporation, Thermo Fisher Scientific Inc., Amcor plc, Berry Global, CCL Industries, Sealed Air Corporation, Huhtamaki Oyj, Catalent Inc., AptarGroup, Schott AG, West Pharmaceuticals Services Inc., Constantia Flexibles Group GmbH, Gerresheimer AG, RPC Group, Klockner Pentaplast Group, Stevanato Group, Bemis Company, Corden Pharma GmbH, LTS Lohmann Therapie-Systeme AG, PCI Pharma Services, Comar LLC, Renaissance Lakewood LLC, Mikart LLC, Tapemark Company Inc., Bilcare Research, Medical Packaging Inc, American Health Packaging, Aphena Pharma Solutions

North America was the largest region in the unit dose manufacturing market in 2024. The regions covered in the unit dose manufacturing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the unit dose manufacturing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The unit dose manufacturing market consists of sales of sachets, small bottles, tubes, and pods. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Unit Dose Manufacturing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on unit dose manufacturing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for unit dose manufacturing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The unit dose manufacturing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product: Liquid Unit Dose; Solid Unit Dose; Other Products
• 2) By Sourcing: In-House; Outsourcing
• 3) By End-User: Independent Pharmacies; Long Term Care Facility; Hospitals; Other End-Users
• Subsegments:
• 1) By Liquid Unit Dose: Liquid Vials; Ampoules; Pre-filled Syringes
• 2) By Solid Unit Dose: Tablets; Capsules; Powder Packs
• 3) By Other Products: Transdermal Patches; Inhalation Doses; Creams And Ointments In Unit Dose Packaging
• Companies Mentioned: Nipro Corporation; Thermo Fisher Scientific Inc.; Amcor plc; Berry Global; CCL Industries
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Unit Dose Manufacturing Market Characteristics

3. Unit Dose Manufacturing Market Trends And Strategies

4. Unit Dose Manufacturing Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global Unit Dose Manufacturing Growth Analysis And Strategic Analysis Framework

• 5.1. Global Unit Dose Manufacturing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Unit Dose Manufacturing Market Growth Rate Analysis
• 5.4. Global Unit Dose Manufacturing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Unit Dose Manufacturing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Unit Dose Manufacturing Total Addressable Market (TAM)

6. Unit Dose Manufacturing Market Segmentation

• 6.1. Global Unit Dose Manufacturing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Liquid Unit Dose
• Solid Unit Dose
• Other Products
• 6.2. Global Unit Dose Manufacturing Market, Segmentation By Sourcing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• In-House
• Outsourcing
• 6.3. Global Unit Dose Manufacturing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Independent Pharmacies
• Long Term Care Facility
• Hospitals
• Other End-Users
• 6.4. Global Unit Dose Manufacturing Market, Sub-Segmentation Of Liquid Unit Dose, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Liquid Vials
• Ampoules
• Pre-filled Syringes
• 6.5. Global Unit Dose Manufacturing Market, Sub-Segmentation Of Solid Unit Dose, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Tablets
• Capsules
• Powder Pack
• 6.6. Global Unit Dose Manufacturing Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Transdermal Patches
• Inhalation Doses
• Creams And Ointments In Unit Dose Packaging

7. Unit Dose Manufacturing Market Regional And Country Analysis

• 7.1. Global Unit Dose Manufacturing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Unit Dose Manufacturing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Unit Dose Manufacturing Market

• 8.1. Asia-Pacific Unit Dose Manufacturing Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Unit Dose Manufacturing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Unit Dose Manufacturing Market, Segmentation By Sourcing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Unit Dose Manufacturing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Unit Dose Manufacturing Market

• 9.1. China Unit Dose Manufacturing Market Overview
• 9.2. China Unit Dose Manufacturing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Unit Dose Manufacturing Market, Segmentation By Sourcing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Unit Dose Manufacturing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Unit Dose Manufacturing Market

• 10.1. India Unit Dose Manufacturing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Unit Dose Manufacturing Market, Segmentation By Sourcing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Unit Dose Manufacturing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Unit Dose Manufacturing Market

• 11.1. Japan Unit Dose Manufacturing Market Overview
• 11.2. Japan Unit Dose Manufacturing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Unit Dose Manufacturing Market, Segmentation By Sourcing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Unit Dose Manufacturing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Unit Dose Manufacturing Market

• 12.1. Australia Unit Dose Manufacturing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Unit Dose Manufacturing Market, Segmentation By Sourcing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Unit Dose Manufacturing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Unit Dose Manufacturing Market

• 13.1. Indonesia Unit Dose Manufacturing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Unit Dose Manufacturing Market, Segmentation By Sourcing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Unit Dose Manufacturing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Unit Dose Manufacturing Market

• 14.1. South Korea Unit Dose Manufacturing Market Overview
• 14.2. South Korea Unit Dose Manufacturing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Unit Dose Manufacturing Market, Segmentation By Sourcing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Unit Dose Manufacturing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Unit Dose Manufacturing Market

• 15.1. Western Europe Unit Dose Manufacturing Market Overview
• 15.2. Western Europe Unit Dose Manufacturing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Unit Dose Manufacturing Market, Segmentation By Sourcing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Unit Dose Manufacturing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Unit Dose Manufacturing Market

• 16.1. UK Unit Dose Manufacturing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Unit Dose Manufacturing Market, Segmentation By Sourcing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Unit Dose Manufacturing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Unit Dose Manufacturing Market

• 17.1. Germany Unit Dose Manufacturing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Unit Dose Manufacturing Market, Segmentation By Sourcing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Unit Dose Manufacturing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Unit Dose Manufacturing Market

• 18.1. France Unit Dose Manufacturing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Unit Dose Manufacturing Market, Segmentation By Sourcing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Unit Dose Manufacturing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Unit Dose Manufacturing Market

• 19.1. Italy Unit Dose Manufacturing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Unit Dose Manufacturing Market, Segmentation By Sourcing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Unit Dose Manufacturing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Unit Dose Manufacturing Market

• 20.1. Spain Unit Dose Manufacturing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Unit Dose Manufacturing Market, Segmentation By Sourcing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Unit Dose Manufacturing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Unit Dose Manufacturing Market

• 21.1. Eastern Europe Unit Dose Manufacturing Market Overview
• 21.2. Eastern Europe Unit Dose Manufacturing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Unit Dose Manufacturing Market, Segmentation By Sourcing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Unit Dose Manufacturing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Unit Dose Manufacturing Market

• 22.1. Russia Unit Dose Manufacturing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Unit Dose Manufacturing Market, Segmentation By Sourcing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Unit Dose Manufacturing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Unit Dose Manufacturing Market

• 23.1. North America Unit Dose Manufacturing Market Overview
• 23.2. North America Unit Dose Manufacturing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Unit Dose Manufacturing Market, Segmentation By Sourcing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Unit Dose Manufacturing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Unit Dose Manufacturing Market

• 24.1. USA Unit Dose Manufacturing Market Overview
• 24.2. USA Unit Dose Manufacturing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Unit Dose Manufacturing Market, Segmentation By Sourcing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Unit Dose Manufacturing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Unit Dose Manufacturing Market

• 25.1. Canada Unit Dose Manufacturing Market Overview
• 25.2. Canada Unit Dose Manufacturing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Unit Dose Manufacturing Market, Segmentation By Sourcing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Unit Dose Manufacturing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Unit Dose Manufacturing Market

• 26.1. South America Unit Dose Manufacturing Market Overview
• 26.2. South America Unit Dose Manufacturing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Unit Dose Manufacturing Market, Segmentation By Sourcing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Unit Dose Manufacturing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Unit Dose Manufacturing Market

• 27.1. Brazil Unit Dose Manufacturing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Unit Dose Manufacturing Market, Segmentation By Sourcing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Unit Dose Manufacturing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Unit Dose Manufacturing Market

• 28.1. Middle East Unit Dose Manufacturing Market Overview
• 28.2. Middle East Unit Dose Manufacturing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Unit Dose Manufacturing Market, Segmentation By Sourcing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Unit Dose Manufacturing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Unit Dose Manufacturing Market

• 29.1. Africa Unit Dose Manufacturing Market Overview
• 29.2. Africa Unit Dose Manufacturing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Unit Dose Manufacturing Market, Segmentation By Sourcing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Unit Dose Manufacturing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Unit Dose Manufacturing Market Competitive Landscape And Company Profiles

• 30.1. Unit Dose Manufacturing Market Competitive Landscape
• 30.2. Unit Dose Manufacturing Market Company Profiles
  • 30.2.1. Nipro Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Amcor plc Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Berry Global Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. CCL Industries Overview, Products and Services, Strategy and Financial Analysis

31. Unit Dose Manufacturing Market Other Major And Innovative Companies

• 31.1. Sealed Air Corporation
• 31.2. Huhtamaki Oyj
• 31.3. Catalent Inc.
• 31.4. AptarGroup
• 31.5. Schott AG
• 31.6. West Pharmaceuticals Services Inc.
• 31.7. Constantia Flexibles Group GmbH
• 31.8. Gerresheimer AG
• 31.9. RPC Group
• 31.10. Klockner Pentaplast Group
• 31.11. Stevanato Group
• 31.12. Bemis Company
• 31.13. Corden Pharma GmbH
• 31.14. LTS Lohmann Therapie-Systeme AG
• 31.15. PCI Pharma Services

32. Global Unit Dose Manufacturing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Unit Dose Manufacturing Market

34. Recent Developments In The Unit Dose Manufacturing Market

35. Unit Dose Manufacturing Market High Potential Countries, Segments and Strategies

• 35.1 Unit Dose Manufacturing Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Unit Dose Manufacturing Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Unit Dose Manufacturing Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer